Ascendis Pharma A/S (ASND) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$234.53
Day's range
$244.55

Ascendis Pharma A/S Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 08/14/2026 10.28 M $2.74 B   100.00% 16.67%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 08/14/2026 6.75 M $1.80 B   9.62% 10.95%
AVORO CAPITAL ADVISORS LLC 08/14/2026 5.11 M $1.36 B   100.00% 8.29%
WESTFIELD CAPITAL MANAGEMENT CO LP 08/12/2026 4.80 M $1.28 B   100.00% 7.78%
JUPITER TOPCO LLC 08/14/2026 3.65 M $973.38 M   100.00% 5.92%
FMR LLC 08/13/2026 3.55 M $945.68 M   100.00% 5.75%
ARTISAN PARTNERS LIMITED PARTNERSHIP 08/13/2026 2.63 M $702.55 M   100.00% 4.27%
BLACKROCK, INC. 08/07/2026 2.21 M $589.94 M   100.00% 3.59%
CAPITAL INTERNATIONAL INVESTORS 08/12/2026 1.99 M $530.40 M   100.00% 3.22%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 08/03/2026 1.88 M $500.14 M   100.00% 3.04%
FRANKLIN RESOURCES INC 08/13/2026 1.86 M $496.77 M   100.00% 3.02%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 1.55 M $413.05 M   100.00% 2.51%
AMERICAN CENTURY COMPANIES INC 08/12/2026 1.40 M $373.56 M   100.00% 2.27%
PERCEPTIVE ADVISORS LLC 08/14/2026 1.16 M $310.39 M   100.00% 1.89%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 1.12 M $299.40 M   -26.65% 1.82%
CAPITAL WORLD INVESTORS 08/12/2026 906.08 K $241.67 M   100.00% 1.47%
PRINCIPAL FINANCIAL GROUP INC 08/04/2026 873.50 K $232.98 M   100.00% 1.42%
POLAR CAPITAL HOLDINGS PLC 08/14/2026 616.91 K $164.54 M   100.00% 1.00%
GOLDMAN SACHS GROUP INC 08/14/2026 559.53 K $149.24 M   100.00% 0.91%
MORGAN STANLEY 08/13/2026 544.39 K $145.20 M   100.00% 0.88%
STATE STREET CORP 08/07/2026 513.97 K $137.09 M   488.51% 0.83%
INVESCO LTD. 08/14/2026 414.20 K $110.47 M   100.00% 0.67%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 403.15 K $107.53 M   100.00% 0.65%
UBS GROUP AG 08/13/2026 401.88 K $107.19 M   100.00% 0.65%
ALLIANCEBERNSTEIN L.P. 08/14/2026 399.29 K $106.50 M   100.00% 0.65%
VESTAL POINT CAPITAL, LP 08/14/2026 375.00 K $100.02 M   100.00% 0.61%
JPMORGAN CHASE & CO 08/12/2026 367.78 K $96.98 M   100.00% 0.60%
FIL LTD 08/13/2026 345.57 K $92.17 M   100.00% 0.56%
AMERIPRISE FINANCIAL INC 08/14/2026 320.51 K $85.49 M   100.00% 0.52%
BANK OF NEW YORK MELLON CORP 08/06/2026 319.41 K $85.19 M   100.00% 0.52%
TWO SIGMA INVESTMENTS, LP 08/14/2026 305.80 K $81.56 M   100.00% 0.50%
MILLENNIUM MANAGEMENT LLC 08/14/2026 266.71 K $71.14 M   100.00% 0.43%
BANK OF AMERICA CORP /DE/ 08/14/2026 260.64 K $69.52 M   100.00% 0.42%
TRI LOCUM PARTNERS LP 08/14/2026 258.74 K $69.01 M   100.00% 0.42%
ORBIMED ADVISORS LLC 08/14/2026 244.46 K $65.20 M   100.00% 0.40%
SEI INVESTMENTS CO 08/14/2026 237.87 K $63.44 M   100.00% 0.39%
PICTET ASSET MANAGEMENT HOLDING SA 07/30/2026 234.04 K $62.27 M   100.00% 0.38%
PFM HEALTH SCIENCES, LP 08/14/2026 233.17 K $62.19 M   100.00% 0.38%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 08/14/2026 225.16 K $60.05 M   68.87% 0.37%
SPYGLASS CAPITAL MANAGEMENT LLC 08/14/2026 215.40 K $57.45 M   100.00% 0.35%
ARS INVESTMENT PARTNERS, LLC 07/09/2026 210.46 K $56.13 M   100.00% 0.34%
SILVERARC CAPITAL MANAGEMENT, LLC 08/13/2026 206.23 K $55.01 M   100.00% 0.33%
NEW YORK STATE COMMON RETIREMENT FUND 07/29/2026 191.79 K $51.15 M   100.00% 0.31%
EMPOWERED FUNDS, LLC 08/17/2026 187.27 K $49.95 M   100.00% 0.30%
JANE STREET GROUP, LLC 08/14/2026 187.14 K $49.91 M   100.00% 0.30%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 08/13/2026 178.74 K $47.86 M   100.00% 0.29%
CITADEL ADVISORS LLC 08/14/2026 175.80 K $46.89 M   100.00% 0.29%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 173.45 K $46.26 M   100.00% 0.28%
FRED ALGER MANAGEMENT, LLC 08/14/2026 171.45 K $45.73 M   100.00% 0.28%
ROCK SPRINGS CAPITAL MANAGEMENT LP 08/14/2026 168.75 K $45.01 M   100.00% 0.27%

Ascendis Pharma A/S institutional Ownership - FAQ's

During the previous two years, 416 institutional investors and hedge funds held shares of Ascendis Pharma A/S. The most heavily invested institutionals were:

RA CAPITAL MANAGEMENT, L.P.: 10.28 M

T. Rowe Price Investment Management, Inc.: 6.75 M

Avoro Capital Advisors LLC: 5.11 M

WESTFIELD CAPITAL MANAGEMENT CO LP: 4.8 M

Jupiter Topco LLC: 3.65 M

FMR LLC: 3.55 M

108.48% of Ascendis Pharma A/S stock is owned by institutional investors.

Institutional investors have bought a total of 70.27 M shares in the last 24 months. This purchase volume represents approximately $16.86 B in transactions.